🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can we identify IR-NMIBC patients who can safely undergo Active Surveillance ? #EAU25 We (Wei Shen Tan Roberto Contieri) investigated AS in IR-NMIBC using IBCG risk factors and found: 🔹 Patients with 0 IBCG risk factors were over twice as likely to remain on AS compared to those

Wei Shen Tan Roberto Contieri The latest validation came in 2025 from the Ospedale San Raffaele group Marco Moschini, which applied IBCG risk factors to 174 IR-NMIBC patients eligible for AS Key findings: 🔹 3-year recurrence-free survival (RFS): ✅ 86% for 0 risk factors ⚠️ 76% for 1-2 risk factors 🚨 54% for ≥3

Wei Shen Tan Roberto Contieri Ospedale San Raffaele Marco Moschini Deintensification of treatment for LG IR NMIBC should be considered for all patients. Here in European Urology Oncology we outline our proposed algorithm #EAU25 Wes Kassouf Sarah P. Psutka MD MS Marco Moschini Joan Palou Redorta Paolo Gontero Morgan Roupret Jeremy Teoh Laura S. Mertens Roberto Contieri

Great start to #EAU25 with an important session on treatment deintensification in LG #bladdercancer. Fantastic to see Ashish M. Kamat, MD, MBBS present the IBCG recommendations — a major step forward for personalized care

So proud of my friend and colleague Roberto Contieri speaking on bladder preservation modalities in MIBC at #EAU25! From starting residency together in 2019 to enduring those tough OR moments, it’s inspiring to see how far you've come.

Germline testing for risk stratification in low-grade #BladderCancer on active surveillance. Roberto Contieri Humanitas Milano joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss active surveillance for low-risk #NMIBC and novel approaches to patient selection. #WatchNow >

Mentorship is the cornerstone of academic growth. I’ll always be deeply thankful to Dr. Kamat for his generous guidance and unwavering support over the years.

Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2–5 pm 🗓️ #AUA25 Amer. Urol. Assn. IBCG Kelly Bree Petros Grivas Laura Bukavina Shilpa Gupta Neha Vapiwala Wes Kassouf Peter Black Patrick Hensley, MD Hikmat Al Ahmadie Joshua Meeks Benjamin Pradere Sia Daneshmand, M.D. Vignesh Packiam, MD

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

Here my #AUA25 list Amer. Urol. Assn.

Proud and grateful to work with the incredible IBCG team, leading global efforts to deliver better treatments, stronger guidelines, for patients worldwide #AUA25 Amer. Urol. Assn. #AUATV Roger Li Shilpa Gupta Patrick Hensley, MD Petros Grivas Sia Daneshmand, M.D. Laura Bukavina

Debate 5. Active Surveillance for LG Intermediate Risk Bladder Cancer #AUA25 Wei Shen Tan Roberto Contieri Laura Bukavina Risk factors matter! Delay in TURBT = potential for upstaging, frequent cystos = anxiety, logistical and financial burden. @Mroupret Active Surveillance

Neoadjuvant mitomycin C before TURBT showed a favorable safety profile in patients with #NMIBC, according to findings from a phase 3, prospective, single-center, randomized trial presented at #AUA25. #blcsm | Roberto Contieri Humanitas Milano hubs.li/Q03kxcmR0

On May 16th, @Synergy_uro will feature a case-based MDT session entirely dedicated to #Bladder #Cancer with YAU Urothelial group members leading lectures, moderation, and MDT discussions Laura S. Mertens Benjamin Pradere Simone Albisinni David D'Andrea Roberto Contieri Andrea Mari

🧠 Multidisciplinary Tumor Board now live at #Synergy! 🎙️ Moderated by Dr. Roberto Contieri & Dr. Marco Finati A stellar expert panel on stage: Prof.s Pradere, Formisano, Imbriaco, Pacelli & Goodyear 🔍🩺 Real cases, real decisions — collaboration at its finest! 🤝💬

Great meeting in Naples! EAU YAU Urothelial Carcinoma present! Thanks to the organisers Savio Domenico Pandolfo Daniele Amparore Riccardo Campi European Association of Urology (EAU)

Congratulations on the success of the SYNERGY It was a real pleasure to return to my med school —thanks to Savio Domenico Pandolfo and the scientific committee. Great to host so many friends in Naples and, most importantly, introduce them to pizza fritta!

Here’s the thread on our newly published editorial on immediate radical cystectomy in very high-risk patients. Congrats to Jose Daniel Subiela the whole team! European Association of Urology (EAU) European Urology

linkedin.com/posts/nicol%C3…

Honored and humbled to receive the Boccafoschi Award for my research in #bladdercancer from UROP, in the wonderful setting of Chia Laguna. Grateful to the scientific committee for this meaningful recognition.